1. Home
  2. BLNK vs MGX Comparison

BLNK vs MGX Comparison

Compare BLNK & MGX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BLNK
  • MGX
  • Stock Information
  • Founded
  • BLNK 2009
  • MGX 2018
  • Country
  • BLNK United States
  • MGX United States
  • Employees
  • BLNK N/A
  • MGX N/A
  • Industry
  • BLNK Industrial Specialties
  • MGX
  • Sector
  • BLNK Consumer Discretionary
  • MGX
  • Exchange
  • BLNK Nasdaq
  • MGX NYSE
  • Market Cap
  • BLNK 77.3M
  • MGX 62.1M
  • IPO Year
  • BLNK N/A
  • MGX 2024
  • Fundamental
  • Price
  • BLNK $0.94
  • MGX $1.57
  • Analyst Decision
  • BLNK Buy
  • MGX Strong Buy
  • Analyst Count
  • BLNK 8
  • MGX 4
  • Target Price
  • BLNK $2.61
  • MGX $13.00
  • AVG Volume (30 Days)
  • BLNK 4.4M
  • MGX 665.7K
  • Earning Date
  • BLNK 08-06-2025
  • MGX 08-13-2025
  • Dividend Yield
  • BLNK N/A
  • MGX N/A
  • EPS Growth
  • BLNK N/A
  • MGX N/A
  • EPS
  • BLNK N/A
  • MGX N/A
  • Revenue
  • BLNK $109,383,000.00
  • MGX $45,263,000.00
  • Revenue This Year
  • BLNK N/A
  • MGX N/A
  • Revenue Next Year
  • BLNK $31.15
  • MGX $11.75
  • P/E Ratio
  • BLNK N/A
  • MGX N/A
  • Revenue Growth
  • BLNK N/A
  • MGX N/A
  • 52 Week Low
  • BLNK $0.63
  • MGX $1.23
  • 52 Week High
  • BLNK $3.75
  • MGX $5.50
  • Technical
  • Relative Strength Index (RSI)
  • BLNK 55.30
  • MGX 51.41
  • Support Level
  • BLNK $0.86
  • MGX $1.45
  • Resistance Level
  • BLNK $0.98
  • MGX $1.66
  • Average True Range (ATR)
  • BLNK 0.08
  • MGX 0.12
  • MACD
  • BLNK -0.00
  • MGX 0.01
  • Stochastic Oscillator
  • BLNK 54.26
  • MGX 66.67

About BLNK Blink Charging Co.

Blink Charging Co is an owner, operator, and provider of electric vehicle (EV) charging services. The company offers both residential and commercial EV charging equipment, enabling EV drivers to easily recharge at various location types. The company's business is the sale and distribution of electric vehicle charging equipment and its associated revenues earned from customers and/or Property Partners who use equipment connected to its network. It earns a majority of revenue from U.S.A.

About MGX METAGENOMI INC

Metagenomi Inc is a genetic medicines company committed to developing curative therapeutics for patients using its proprietary, comprehensive metagenomics-derived genome editing toolbox. The genome editing toolbox includes systems for making small edits such as programmable nucleases, base editors, small RNA-mediated integration systems (RIGS), as well as large gene integration systems including large template RIGS and CRISPR-associated transposases (CASTs). The company is focused on its vivo gene editing for its wholly-owned pipeline while pursuing technology out licensing for ex vivo cell therapy. Its pipeline includes product candidates aimed at addressing disorders like Hemophilia A (through MGX-001), Refractory Hypertension, Cardiovascular diseases, and Wilson's disease, among others.

Share on Social Networks: